Loading
Latest filing published 11 Sept 2026 for Cardiol Therapeutics Inc., €21k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Guillermo Torre discloses dealings in Cardiol Therapeutics Inc. to SEDI. Between 31 March 2021 and 8 September 2026, the trades on record add up to 9 filings.
Every open-market trade on record is a purchase: 2 purchases worth €23k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 4 share grants and 2 option exercises.
On 11 September 2026 came the latest disclosure, an option exercise for €21k in Cardiol Therapeutics Inc. The most recent open-market purchase was published on 13 May 2024, 891 days ago. Filings reach the SEDI feed a median of 5 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations